FERRISI, REBECCA Statistiche
FERRISI, REBECCA
DIPARTIMENTO DI FARMACIA
New Insights into Bitopic Orthosteric/Allosteric Ligands of Cannabinoid Receptor Type 2
2023-01-01 Ferrisi, Rebecca; Polini, Beatrice; Ricardi, Caterina; Gado, Francesca; Mohamed, Kawthar A; Baron, Giovanna; Faiella, Salvatore; Poli, Giulio; Rapposelli, Simona; Saccomanni, Giuseppe; Aldini, Giancarlo; Chiellini, Grazia; Laprairie, Robert B; Manera, Clementina; Ortore, Gabriella
CB1 receptor binding sites for NAM and PAM: A first approach for studying, new n‑butyl‑diphenylcarboxamides as allosteric modulators
2022-01-01 Gado, F.; Ceni, C.; Ferrisi, R.; Sbrana, G.; Stevenson, L. A.; Macchia, M.; Pertwee, R. G.; Bertini, S.; Manera, C.; Ortore, G.
Design, synthesis and biological evaluation of second-generation benzoylpiperidine derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors
2021-01-01 Granchi, C.; Bononi, G.; Ferrisi, R.; Gori, E.; Mantini, G.; Glasmacher, S.; Poli, G.; Palazzolo, S.; Caligiuri, I.; Rizzolio, F.; Canzonieri, V.; Perin, T.; Gertsch, J.; Sodi, A.; Giovannetti, E.; Macchia, M.; Minutolo, F.; Tuccinardi, T.; Chicca, A.
Medicinal Chemistry approach, pharmacology and neuroprotective benefits of CB2R modulators in neurodegenerative diseases
2021-01-01 Ferrisi, R.; Ceni, C.; Bertini, S.; Macchia, M.; Manera, C.; Gado, F.
Variously substituted 2-oxopyridine derivatives: Extending the structure-activity relationships for allosteric modulation of the cannabinoid CB2 receptor
2021-01-01 Gado, F.; Mohamed, K. A.; Meini, S.; Ferrisi, R.; Bertini, S.; Digiacomo, M.; D'Andrea, F.; Stevenson, L. A.; Laprairie, R. B.; Pertwee, R. G.; Manera, C.
Positive allosteric modulation of CB1 and CB2 cannabinoid receptors enhances the neuroprotective activity of a dual CB1R/CB2R orthosteric agonist
2020-01-01 Polini, B.; Cervetto, C.; Carpi, S.; Pelassa, S.; Gado, F.; Ferrisi, R.; Bertini, S.; Nieri, P.; Marcoli, M.; Manera, C.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| New Insights into Bitopic Orthosteric/Allosteric Ligands of Cannabinoid Receptor Type 2 | 1-gen-2023 | Ferrisi, Rebecca; Polini, Beatrice; Ricardi, Caterina; Gado, Francesca; Mohamed, Kawthar A; Baron, Giovanna; Faiella, Salvatore; Poli, Giulio; Rapposelli, Simona; Saccomanni, Giuseppe; Aldini, Giancarlo; Chiellini, Grazia; Laprairie, Robert B; Manera, Clementina; Ortore, Gabriella | |
| CB1 receptor binding sites for NAM and PAM: A first approach for studying, new n‑butyl‑diphenylcarboxamides as allosteric modulators | 1-gen-2022 | Gado, F.; Ceni, C.; Ferrisi, R.; Sbrana, G.; Stevenson, L. A.; Macchia, M.; Pertwee, R. G.; Bertini, S.; Manera, C.; Ortore, G. | |
| Design, synthesis and biological evaluation of second-generation benzoylpiperidine derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors | 1-gen-2021 | Granchi, C.; Bononi, G.; Ferrisi, R.; Gori, E.; Mantini, G.; Glasmacher, S.; Poli, G.; Palazzolo, S.; Caligiuri, I.; Rizzolio, F.; Canzonieri, V.; Perin, T.; Gertsch, J.; Sodi, A.; Giovannetti, E.; Macchia, M.; Minutolo, F.; Tuccinardi, T.; Chicca, A. | |
| Medicinal Chemistry approach, pharmacology and neuroprotective benefits of CB2R modulators in neurodegenerative diseases | 1-gen-2021 | Ferrisi, R.; Ceni, C.; Bertini, S.; Macchia, M.; Manera, C.; Gado, F. | |
| Variously substituted 2-oxopyridine derivatives: Extending the structure-activity relationships for allosteric modulation of the cannabinoid CB2 receptor | 1-gen-2021 | Gado, F.; Mohamed, K. A.; Meini, S.; Ferrisi, R.; Bertini, S.; Digiacomo, M.; D'Andrea, F.; Stevenson, L. A.; Laprairie, R. B.; Pertwee, R. G.; Manera, C. | |
| Positive allosteric modulation of CB1 and CB2 cannabinoid receptors enhances the neuroprotective activity of a dual CB1R/CB2R orthosteric agonist | 1-gen-2020 | Polini, B.; Cervetto, C.; Carpi, S.; Pelassa, S.; Gado, F.; Ferrisi, R.; Bertini, S.; Nieri, P.; Marcoli, M.; Manera, C. |